Lipocine (LPCN) Misses Q2 EPS by 41c

Lipocine (NASDAQ: LPCN) reported Q2 EPS of ($0.41). Revenue for the quarter came in at $620 thousand.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Activist Jana Partners takes 6.3% stake in Alkami Technology, urges sale
• FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing